Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Burn Injuries and Road Accidents
4.2.2 Government Initiatives Regarding Wound Care Treatment
4.3 Market Restraints
4.3.1 High Treatment Cost
4.3.2 Stringent Regulatory Guidelines
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Biological Skin Substitutes
5.1.2 Topical Agents
5.2 By Wound Type
5.2.1 Ulcers
5.2.1.1 Diabetic Foot Ulcers
5.2.1.2 Venous Ulcers
5.2.1.3 Pressure Ulcers
5.2.1.4 Other Ulcers
5.2.2 Surgical & Traumatic Wounds
5.2.3 Burns
5.3 End User
5.3.1 Hospitals/Clinics
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ACell, Inc.
6.1.2 Integra LifeSciences Corporation
6.1.3 Kerecis
6.1.4 Marine Polymer Technologies, Inc.
6.1.5 MiMedx Inc.
6.1.6 MISONIX, Inc.
6.1.7 Molnlycke Health Care
6.1.8 Smith & Nephew plc
6.1.9 Wright Medical Group N.V.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS